Haemonetics Corporation (HAE) 1996年年度报告「NYSE」.pdf

1、 SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended March 29,1997.Commission file number 1-10730 -Haemonetics Corporation (Exact name of registrant as specified in its charter)

2、Massachusetts 04-2882273 (State of Incorporation)(I.R.S.Employer Identification No.)400 Wood Road,Braintree,Massachusetts 02184-9114 (617)848-7100 (Address,including zip code,and telephone number,including area code,of principal executive offices)Securities registered pursuant to Section 12(b)of the

3、 Act:Name of each exchange Title of each class on which registered -Common stock,$.01 par value New York Stock Exchange Securities registered pursuant to Section 12(g)of the Act:None Indicate by check mark whether the registrant(1)has filed all reportsrequired to be filed by Section 13 or 15(d)of th

4、e Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that theregistrant was required to file such reports),and(2)has been subject to suchfiling requirements for the past 90 days.Yes X No .Indicate by check mark if disclosure of delinquent filers pursuant toItem

5、405 of Regulation S-K is not contained herein,and will not be contained,to the best of registrants knowledge,in definitive proxy or informationstatements incorporated by reference in Part III of this Form 10-K or anyamendment to this form 10-K.X The aggregate market value of the voting stock held by

6、 non-affiliates ofthe registrant based on the closing sale price of May 22,1997,wasapproximately$392,000,000.The number of shares of the registrants common stock,$.01 par value,outstanding as of May 22,1997 was 26,798,219.-DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates information by refe